|
Market Closed -
London S.E.
23:20:00 02/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 323.90 CHF | 0.00% |
|
0.00% | -1.29% |
| 09-13 | Roche Outlines Positive Phase 3 Trial Data for Small-cell Lung Cancer Treatment in China | MT |
| 09-12 | Scholar Rock gets first FDA nod for rare muscle-wasting disease (September 11) | RE |
| Market Cap | 277B 333B 296B 252B 475B 32,055B 480B 3,346B 1,297B 16,387B 1,252B 1,225B 52,592B | P/E 2026 * |
18.8x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 287B 347B 308B 262B 494B 33,316B 499B 3,478B 1,348B 17,032B 1,301B 1,273B 54,661B | EV / Sales 2026 * |
4.58x | EV / Sales 2027 * | 4.28x |
| Free-Float |
88.78% | Yield 2026 * |
2.9% | Yield 2027 * | 2.97% |
Last Transcript: Roche Holding AG
| Current month | +0.48% | ||
| Current year | -1.29% |
| Current year | 311.6 |  | 377 |
| 1 year | 258.4 | | 377 |
| 3 years | 212.3 | | 377 |
| 5 years | 212.3 | | 404.1 |
| 10 years | 202.23 | | 404.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 15/03/2023 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 06/06/2011 |
| Chief Operating Officer | - | 01/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 01/01/1996 |
Severin Schwan
CHM | Chairman | 59 | 15/03/2023 |
| Director/Board Member | 73 | 03/03/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 333B | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.68% | -3.39% | +26.07% | +58.90% | 410.8B | |
| Weighted average by Cap. | -0.55% | -3.33% | +29.07% | +71.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.69B 75.6B 67.17B 57.14B 108B 7,267B 109B 759B 294B 3,715B 284B 278B 11,923B | 65.54B 79.04B 70.22B 59.74B 113B 7,598B 114B 793B 307B 3,884B 297B 290B 12,466B |
| Net income | 14.49B 17.48B 15.53B 13.21B 24.91B 1,680B 25.14B 175B 67.96B 859B 65.61B 64.19B 2,756B | 16.32B 19.68B 17.49B 14.88B 28.06B 1,892B 28.32B 198B 76.55B 967B 73.91B 72.3B 3,105B |
| Net Debt | 10.88B 13.12B 11.65B 9.91B 18.7B 1,261B 18.87B 132B 51.01B 645B 49.25B 48.18B 2,069B | 4.03B 4.86B 4.32B 3.68B 6.93B 468B 7B 48.82B 18.92B 239B 18.26B 17.87B 767B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | CHF 323.90 | 0.00% | 3,929 |
| 01/10/26 | CHF 323.90 | 0.00% | 52,729 |
| 30/09/26 | CHF 323.90 | 0.00% | 37,738 |
| 29/09/26 | CHF 323.90 | 0.00% | 7,696 |
| 28/09/26 | CHF 323.90 | 0.00% | 9,693 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROP Stock
- 0QOK Stock
Select your edition
All financial news and data tailored to specific country editions
